Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 4,950.00
0.00 (0.00%)
Nov 13, 2026, 3:30 PM KST
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 118.34 billion as of November 12, 2026. It is the 25,860th most valuable company in the world and the 1,119th biggest in South Korea. Its market cap has decreased by 21.80% in one year.
Market Cap
118.34B
Enterprise Value
262.51B
Revenue
279.55B
Global Rank
Country Rank
#1,119 South Korea
PE Ratio
23.44
ChartMarket Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 118.34B, a decrease of -85.55%. That is a compound annual growth rate of -15.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 118.34B | -14.21% |
| Dec 30, 2025 | 137.94B | -7.23% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dongwha Pharm.Co.,Ltd | 148.29B |
| Daihan Pharmaceutical | 146.71B |
| Hana Pharm | 146.63B |
| Ilsung Is | 144.61B |
| Jeil Pharmaceutical Co.,Ltd | 129.84B |
| AptaBio Therapeutics | 128.25B |
| Ilyang Pharmaceutical Co.,Ltd | 121.53B |
| SAMSUNG PHARM. Co., LTD. | 117.65B |